Quick Heal trading window shuts for Q1 FY27 results

Quick Heal Technologies Ltd has announced the closure of its trading window for dealing in the company’s securities, a routine compliance step ahead of quarterly results. The restriction is linked to the upcoming un-audited financial results for the quarter ended June 30, 2026 (Q1 FY27).

The company said the trading window will remain shut from July 1, 2026 and will reopen 48 hours after the declaration of the results. The date of the board meeting to approve the Q1 FY27 results will be communicated separately.

What the trading window closure means

The trading window closure is part of compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company’s internal code of conduct. Such closures typically restrict directors, designated employees, and other insiders from trading in the company’s securities during the sensitive period before results are announced.

For investors, the key point is procedural rather than operational. The closure does not, by itself, indicate the direction of quarterly performance. It signals that the company is in the results-preparation phase and that the board approval and disclosure are pending.

Dates investors should track

Quick Heal has specified the start date clearly: July 1, 2026. The reopening is defined as 48 hours after the company declares the un-audited Q1 FY27 financial results for the quarter ended June 30, 2026.

The company has not provided the board meeting date in the information shared, noting that it will be disclosed separately through exchange filings.

Q1 FY27: Analyst forecast in the public domain

Separately, an earnings preview published by Uniresearch has projected a weaker year-on-year quarter for Q1 FY27. Uniresearch estimates revenue of ₹46 crore for Q1 FY27, down 18.6% year-on-year, and profit after tax (PAT) of -₹3 crore, improving 50.0% year-on-year from the prior-year loss.

The forecast references Q1 FY26 as the base period, where the company reported revenue of ₹57 crore and PAT of -₹6 crore, according to consolidated quarterly financial data sourced from Screener.in (as cited in the preview).

FY26 and Q4FY26: Audited numbers show losses

Quick Heal’s audited consolidated revenue from operations for FY26 stood at ₹261.02 crore, compared with ₹279.53 crore in FY25, a year-on-year decline of 6.62%. For FY26, the company reported a net loss after tax of ₹10.93 crore, versus a net profit of ₹5.04 crore in FY25. Basic EPS for FY26 was ₹(1.98) compared to ₹0.94 in FY25.

For Q4 FY26, revenue from operations was ₹48.73 crore, down 25.19% year-on-year from ₹65.14 crore in Q4 FY25 and down 31.88% quarter-on-quarter from ₹71.54 crore in Q3 FY26. Total income for Q4 FY26 was ₹52.48 crore, compared with ₹70.74 crore in Q4 FY25.

Profitability trend: EBITDA and PAT pressure

The company reported an EBITDA loss of ₹29.3 crore in Q4 FY26, compared with an EBITDA loss of ₹8.5 crore in Q4 FY25. For FY26, EBITDA was a loss of ₹29.4 crore, versus a loss of ₹6.6 crore in FY25.

On the bottom line, Q4 FY26 net loss was ₹19.94 crore compared with a loss of ₹3.25 crore in Q4 FY25. The widening quarterly loss in Q4 FY26 sits alongside the full-year FY26 net loss of ₹10.93 crore.

Q3FY26 snapshot: Revenue steady, margins weak

Quick Heal’s Q3 FY26 results showed revenue of ₹70.6 crore versus ₹71.5 crore in Q3 FY25, a change of -1%. EBITDA was -₹3.8 crore versus ₹0.5 crore a year earlier, with an EBITDA margin of -5.3% for Q3 FY26. PAT stood at ₹0.1 crore versus ₹6.6 crore in Q3 FY25, a change of -98%, and PAT margin was 0.2%.

These numbers, combined with the sharper deterioration in Q4 FY26, frame why the upcoming Q1 FY27 results will be closely tracked.

Stock and valuation snapshot provided

The information shared includes a price of ₹173 and market capitalisation of about ₹1,131 crore (also presented as ₹1.1K crore). The stock is shown trading at a P/E of 196.4.

A separate performance snapshot lists returns of -3.70% (1 day), -4.97% (5 days), -12.90% (1 month), -35.20% (6 months), -59.79% (1 year), and +47.43% (5 years). Another data point shows -14.29 (-6.72%) as on 22 May 2026 at 14:14.

Key facts table

Company and investor contact details shared

The company’s registered office address is listed as Quick Heal Technologies Limited, Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Viman Nagar, Pune 411014, Maharashtra, India. The nodal officer named is Mr. Sarang Deshpande, and the company secretary contact is cs@quickheal.co.in.

The share registry investor contact shown is investor.helpdesk@in.mpms.mufg.com with phone number +91 22 49186270. Support contact details provided include support@quickheal.com and +91 927 2202 525.

Why this update matters

Trading window closures are a standard governance step, but the timing draws attention to the upcoming Q1 FY27 result cycle. With FY26 ending in a net loss and Q4 FY26 showing a sharp drop in revenue and a wider EBITDA loss, investors may use the Q1 FY27 release to assess whether operational performance has stabilised.

Separately, the presence of a published forecast for Q1 FY27 (revenue ₹46 crore and PAT -₹3 crore) sets a reference point that market participants may compare with the company’s reported numbers once declared.

Conclusion

Quick Heal’s trading window is closed from July 1, 2026 and will reopen 48 hours after the Q1 FY27 results are declared, with the board meeting date to be communicated separately. The next key milestone is the formal results announcement for the quarter ended June 30, 2026.